The British Association for the Study of the Liver is the National Association for hepatology. BASL is dedicated to advancing knowledge and understanding of the biology and pathology of the liver for the optimal care of patients. BASL is composed of interested individuals from clinical medicine, clinical and basic research and allied professions.

The BASL umbrella incorporates four Sub-Groups and a number of Special Interest Groups:

  •  BLNA (British Liver Nurses' Association)
  •  BVHG (British Viral Hepatitis Group)
  •  BLTG (British Liver Transplant Group)
  •  BHPG (British Hepatology Pharmacy Group)

Special Interest Groups:

  • Acute liver failure
  • Alcohol related liver disease
  • Cholangiocarcinoma-UK
  • End of life
  • HBV
  • HCC-UK
  • Immune-mediated liver disease
  • Portal hypertension
  • Rare Diseases; Wilson’s Disease and Alpha-1 antitrypsin deficiency
  • Acute on Chronic Liver Failure (including frailty and sarcopenia)

BASL aims to:

Disseminate research findings and clinical expertise in liver disease;

Promote and provide opportunities for collaboration in liver research;

Provide a voice that can advise and interact with the media to raise awareness of liver disease within the UK;

To advise policymakers within the health service how to advance the provision of care for patients with liver disease within the UK;

BASL is a not for profit Association whose income is derived from membership fees, donations and its various activities, such as the revenue of scientific meetings. Monies derived from such activities are used to support further educational events and the attendance thereto of its members.

BASL Annual Meeting:

The BASL Annual Meeting 2021 is being planned for 21st - 24th September and will include the BLTG and BLNA meetings.  With the challenges of the COVID-19 pandemic it is not known yet if the meeting will be held as a hybrid meeting or virtually as in 2020.  Further details will be shared on the Events page of the website when confirmed.